一个用于SpyCatcher对本地抗体的结合平台
Sona Krajcovicova1,2, Thomas Wharton1, Claudia L Driscoll3,4
1Yusuf Hamied Department of Chemistry University of Cambridge Lensfield Road CB2 1EW Cambridge UK spring@ch.cam.ac.uk.
Chemical science
|May 19, 2025
概括
一种新的方法可以使用SpyTag/SpyCatcher系统和新型链接器实现快速,稳定的蛋白质-抗体结合. 该平台通过简化抗体生物结合来推进向治疗和诊断,用于药物开发.
科学领域:
- 生物结合化学 生物结合化学
- 蛋白质工程是指蛋白质工程.
- 开发治疗性抗体 开发治疗性抗体
背景情况:
- 蛋白质-抗体结合物对于向疗法至关重要.
- 现有的"现成"抗体结合平台是有限的.
- 该SpyTag/SpyCatcher系统通过异类键提供了强大的蛋白质结合.
研究的目的:
- 开发一种用于快速稳定的"现成"抗体结合的新平台.
- 使用专门的链接器将SpyCatcher与本地抗体融合在一起.
- 为了证明平台的效率和广泛适用性.
主要方法:
- 通过对氨酸有反应的四乙烯胺 (TetraDVP) -SpyTag链接器,SpyCatcher与本地抗体的融合.
- 对Trastuzumab (针对HER2的抗体) 与SpyCatcher蛋白质的结合.
- 测试对HER2阳性细胞的结合效率和结合亲和力.
- 其他IgG1和IgG4抗体的结合 (杜尔瓦卢马布,布伦图西马布,塞图西马布,吉姆图祖马布).
- 为TetraDVP链接器开发可扩展的固相合成.
主要成果:
- 产生了强大的蛋白质-抗体结合体,具有高的转化率.
- 结合物保留了对HER2阳性细胞的特定结合.
- 这种TetraDVP-SpyTag链接器在多种原生IgG1和IgG4抗体中表现出广泛的适用性.
- 实现了TetraDVP链接器可扩展的固相合成,实现了高产量和纯度.
结论:
- 开发的平台可以实现精确的,单步抗体生物结合.
- 这种方法显著推进了用于治疗和诊断的蛋白质-抗体结合合成.
- 该平台为基于抗体的药物开发提供了一个强大的工具.
更多相关视频
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
3.4K
08:21Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
Published on: May 23, 2025
152
相关概念视频
01:20Immunoprecipitation
5.3K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.3K
01:33Enzyme-Linked Immunosorbent Assay
12.5K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
12.5K